-
Overcoming EGFR-TKI Resistance: Johnson & Johnson's Dual Antibody Challenges the Third Generation EG...
EGFR-TKIs (epidermal growth factor receptor-tyrosine kinase inhibitors) have revolutionized the treatment of non-small cell lung cancer (NSCLC), parti...
2024-03-13 11:27 -
Revolutionary Mechanism of New Weight-Loss Drug Propels Stock Price Surge - A Game-Changer in the Gl...
Laekna Therapeutics revealed the acceptance of its clinical trial application for a novel weight-loss drug, LAE102, by China's Center for Drug Evaluat...
2024-03-13 11:25 -
Struggling Biotech Company Faces 95% Market Value Drop and Implements Two Rounds of Layoffs in Four ...
In a challenging turn of events, KronosBio, a prominent biotech company listed on NASDAQ, has witnessed a staggering 95% decline in its market value.
2024-03-13 11:21 -
The Next Frontier in Medicine: Microbiome Therapy
In the era of groundbreaking medical advancements such as ADCs, oligonucleotides, and gene editing, a new form of therapy is emerging as the next fron...
2024-03-13 11:16 -
Breakthrough Results Unveiled: ASC40, a Novel FASN Inhibitor, Shows Promise in Treating Moderate Acn...
ASC40, a groundbreaking fatty acid synthase (FASN) inhibitor, has recently made waves in the field of dermatology.
2024-03-11 17:15 -
Kanion Pharmaceutical Achieves Impressive Growth in 2023: Net Profit Rises by 23.54%
Kanion Pharmaceutical, a leading player in the pharmaceutical industry, has recently released its financial report for the year 2023.
2024-03-11 17:13 -
Breakthroughs in Claudin 18.2 ADC Unveiled: A Promising Milestone
In recent developments, significant advancements have been made in the field of Claudin 18.2 Antibody-Drug Conjugates (ADCs), marking a breakthrough i...
2024-03-11 17:10 -
Breakthrough in Chinese Biopharmaceutical Industry: $800 Million Down Payment Received
In the realm of innovative pharmaceuticals, China continues to witness remarkable leaps forward.
2024-03-11 17:04 -
Novo Nordisk, Valued at $600 Billion, Sets Sights on Expanding into the Chinese Market
Novo Nordisk, a pharmaceutical giant with a market valuation of $600 billion, is making significant strides to tap into the Chinese market.
2024-03-11 16:50 -
Unveiling the Future Direction of Innovative Medicines in 2024
As we step into the year 2024, the winds of innovation continue to shape the landscape of the pharmaceutical industry.
2024-03-07 15:19
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
- Wanhua Chemical Boosts TDI Cap... Aug 24, 2025
Related Products
Related Producers
